We are live on ! Find out more
TS

Thomas Steyer Farallon Capital Management

AUM $21.7B
1-Year Est. Return 79.24%
 

Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.

This Fund
S&P 500
This Quarter Est. Return
+2.04%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$23.3B
AUM Growth
-$265M
Cap. Flow
-$917M
Cap. Flow %
-3.93%
Top 10 Hldgs %
47.97%
Holding
197
New
23
Increased
32
Reduced
40
Closed
30

Top Buys

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$386M
2
AON icon
Aon
AON
+$368M
3
CTLT
CATALENT, INC.
CTLT
+$282M
4
CRM icon
Salesforce
CRM
+$266M
5
HCP
HashiCorp, Inc. Class A Common Stock
HCP
+$184M

Top Sells

Rank Stock Value
1
PXD
Pioneer Natural Resource Co.
PXD
+$924M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$262M
3
CSGP icon
CoStar Group
CSGP
+$251M
4
INSP icon
Inspire Medical Systems
INSP
+$135M
5
WAB icon
Wabtec
WAB
+$123M

Sector Composition

Rank Sector Weight
1 Healthcare 29.33%
2 Technology 12.47%
3 Financials 9.64%
4 Industrials 5.44%
5 Communication Services 5.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMGN icon
51
Amgen
AMGN
$238B
$72.5M 0.31%
+232,000
New +$68.2M
GERN icon
52
Geron
GERN
$977M
$71.4M 0.31%
16,837,000
+9,342,000
+125% +$36.4M
BEKE icon
53
KE Holdings
BEKE
$19.6B
$67.1M 0.29%
4,740,833
– –
X
54
DELISTED
US Steel
X
$64.6M 0.28%
1,710,000
-1,480,000
-46% -$56.5M
ICLR icon
55
Icon
ICLR
$13.3B
$55.9M 0.24%
178,200
-1,500
-0.8% -$470K
COR icon
56
Cencora
COR
$60.7B
$54.7M 0.23%
242,800
-91,200
-27% -$21.1M
CERE
57
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$48.7M 0.21%
1,190,000
+127,000
+12% +$5.29M
SIMO icon
58
Silicon Motion
SIMO
$8.76B
$46M 0.2%
567,534
-287,915
-34% -$22.5M
UTHR icon
59
United Therapeutics
UTHR
$22B
$45.6M 0.2%
143,000
+33,000
+30% +$8.73M
INSM icon
60
Insmed
INSM
$27.5B
$38.1M 0.16%
+568,000
New +$22M
PGNY icon
61
Progyny
PGNY
$1.97B
$37.4M 0.16%
1,308,500
+715,900
+121% +$21.6M
FLUT icon
62
Flutter Entertainment
FLUT
$17.8B
$36.6M 0.16%
+200,800
New +$38.6M
CRSP icon
63
CRISPR Therapeutics
CRSP
$5.75B
$28.6M 0.12%
+530,000
New +$30.7M
ENTA icon
64
Enanta Pharmaceuticals
ENTA
$392M
$27.2M 0.12%
2,095,000
– –
CHX
65
DELISTED
ChampionX
CHX
$26.1M 0.11%
+785,000
New +$26.8M
AXNX
66
DELISTED
Axonics, Inc. Common Stock
AXNX
$24.9M 0.11%
370,000
+145,000
+64% +$9.77M
LQDA icon
67
Liquidia Corp
LQDA
$6.14B
$24.7M 0.11%
2,055,000
– –
CRNX icon
68
Crinetics Pharmaceuticals
CRNX
$8.99B
$22.3M 0.1%
497,000
+492,000
+9,840% +$22.7M
PCVX icon
69
Vaxcyte
PCVX
$9.32B
$21.9M 0.09%
290,000
-87,400
-23% -$5.95M
SRPT icon
70
CALL
Sarepta Therapeutics
SRPT
$1.98B
$21.1M 0.09%
+133,300
New +$17.1M
DFS
71
DELISTED
Discover Financial Services
DFS
$20.9M 0.09%
160,000
– –
SVRA icon
72
Savara
SVRA
$1.15B
$18.4M 0.08%
4,560,000
+2,165,701
+90% +$9.64M
VYGR icon
73
Voyager Therapeutics
VYGR
$209M
$18.1M 0.08%
2,292,000
– –
CNTA
74
DELISTED
Centessa Pharmaceuticals
CNTA
$18M 0.08%
1,996,000
+1,625,000
+438% +$15.4M
SYRE icon
75
Spyre Therapeutics
SYRE
$9.39B
$15.7M 0.07%
666,000
+200,000
+43% +$6.75M
1 2
3
4 5

Similar funds

BG
Bahl & Gaynor Cincinnati, Ohio $21.7B AUM 30.58% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $21.7B AUM 41.93% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $21.5B AUM 23.65% 1-Year Est. Return
CHP
Castle Hook Partners New York $21.8B AUM 215.45% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Thomas Steyer's Q2 2024 Portfolio in Review

As of Q2 2024, Thomas Steyer held 197 positions worth $23.3B, down 1.1% from $23.6B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Thomas Steyer withdrew a net $917M in Q2 2024, closing 30 positions and reducing 40 holdings. Its most notable exit was Pioneer Natural Resource Co., an estimated $924M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 27% a quarter earlier, followed by Technology and Financials.

Against the trend, Thomas Steyer opened a new position in Walt Disney worth $356M.

  • Thomas Steyer's largest Q2 2024 buy was Walt Disney: 3,582,168 shares worth $356M.
  • Thomas Steyer added most to Aon in Q2 2024, an estimated $368M increase.
  • Thomas Steyer's biggest Q2 2024 reduction was Alphabet (Google) Class C, cutting an estimated $262M.
  • Thomas Steyer fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $924M.
  • Thomas Steyer's ten largest holdings make up 48% of its $23.3B portfolio in Q2 2024.
  • Thomas Steyer opened 23 new positions and closed 30 in Q2 2024.
  • Thomas Steyer's portfolio value fell 1.1% quarter-over-quarter to $23.3B.

Based on Farallon Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.